Multivitamins & Aging: What the COSMOS Study Found

For years, the mainstream health consensus has been fairly dismissive of multivitamins. "Expensive urine" is the phrase that gets thrown around most. Yet a March 2026 study published in Nature Medicine suggests something more complicated might be happening — specifically, that a daily multivitamin may slow the rate of epigenetic aging by approximately 1.5 to 2 months per year compared to placebo.

The study is the COSMOS trial: roughly 21,000 participants, randomized, three-year follow-up. The finding is counterintuitive enough that it warrants a careful look at what the data actually shows, what it does not show, and how you might track something similar in your own biology.

One detail worth noting upfront: the cocoa extract arm of the same trial did NOT show the same effect. The beneficial signal was specifically from the multivitamin, not the flavanols. That asymmetry is part of what makes this result interesting rather than generic.

What Are Epigenetic Clocks?

To understand why this finding matters, it helps to understand the difference between chronological age and biological age.

Chronological age is simply how many years you have been alive. Biological age is a measurement of how "old" your cells appear to be functioning — and those two numbers are not always the same person.

Epigenetic clocks are one of the most validated tools for estimating biological age. They work by measuring DNA methylation patterns: chemical tags on your DNA that change predictably over time but can be accelerated or slowed by lifestyle, disease, and environment. Researchers have developed multiple validated clocks — GrimAge, PhenoAge, and the Horvath clock are among the most cited — each trained on large datasets to predict biological outcomes like mortality risk and disease onset.

If your epigenetic clock reads younger than your chronological age, research suggests you may be aging more slowly at the cellular level. If it reads older, the reverse applies. These clocks don't measure any single marker; they look at methylation patterns across hundreds of genomic sites and produce a composite estimate.

The COSMOS study used specific validated epigenetic clocks to measure whether the intervention arms showed differences in the rate of biological aging over three years. That's a meaningful methodological choice — it's not self-reported wellness, it's a molecular readout.

Related: Try our Supplement Stack Audit to test this yourself. Also worth reading: Anti-Aging Supplements Ranked by Research and our The Complete Guide to Supplement Tracking.

The COSMOS Study

COSMOS stands for Cocoa Supplement and Multivitamin Outcomes Study. It was led by researchers at Harvard and Brigham and Women's Hospital and published in Nature Medicine in March 2026.

The design was a 2x2 factorial randomized controlled trial: approximately 21,000 participants were assigned to one of four conditions — Centrum Silver alone, cocoa extract (500mg flavanols) alone, both combined, or placebo. The follow-up period was three years.

The primary finding for epigenetic aging: participants in the multivitamin arm showed a slower rate of epigenetic clock aging compared to placebo, estimated at approximately 1.5 to 2 months per year. Over three years, that compounds to roughly 4.5 to 6 months of slower biological aging relative to placebo.

The cocoa extract group did not show this effect. That's notable because cocoa flavanols have strong theoretical reasons to benefit cardiovascular and cognitive health, and earlier phases of the COSMOS study did find cardiovascular benefits from cocoa. But on the epigenetic aging outcome, the signal came from the multivitamin arm specifically.

Why? The study does not answer that question. Centrum Silver contains around 30 micronutrients, and identifying which ingredient — or combination of ingredients — is responsible for the methylation signal is a separate research question that will take years to untangle.

What the Evidence Does and Does NOT Mean

This is the part that deserves the most careful reading.

Epigenetic clocks are surrogate endpoints. They correlate with longevity and disease risk in large datasets, but they do not directly measure lifespan. A study showing that an intervention slows an epigenetic clock is not the same as a study showing that the intervention extends human life. That distinction is not a technicality — it's the core epistemological issue with most longevity research right now.

The effect size is also modest. One and a half to two months per year of slower epigenetic aging is meaningful in the context of a cheap, low-risk supplement — but it is not a dramatic anti-aging intervention. For comparison:

• Rapamycin has stronger animal longevity data than almost any other compound, but the human evidence is limited and side effects are significant enough that most physicians won't prescribe it off-label without careful monitoring.
• NMN and NR (NAD+ precursors) have generated significant enthusiasm, but the human evidence remains mixed. Most trials are small, short, and underpowered for hard outcomes.
• Taurine was the subject of a 2023 Science paper showing dramatic longevity effects in worms, mice, and monkeys — but human RCT data is still early.

Against that landscape, a large, well-powered RCT finding a modest signal in multivitamins is actually more actionable than many alternatives — not because the effect is larger, but because the evidence quality is higher and the risk-to-cost ratio is favorable.

That said, this is one RCT. Independent replication is needed before any strong conclusions are warranted. And the specific formulation tested was Centrum Silver — other multivitamins with different micronutrient profiles have not been tested in this context.

How to Track Whether Your Multivitamin Is Working

This is where self-experimentation becomes relevant. The COSMOS study was a population-level trial — it tells you what happened on average across 21,000 people. It does not tell you what would happen in your specific biology.

If you want to generate your own signal, a structured tracking protocol is more useful than guessing.

Biological age tests currently range from roughly $200 to $400 per test, which makes quarterly testing impractical for most people. Once or twice a year is a reasonable cadence for tracking longitudinal change.

Pros and Cons at a Glance

Frequently Asked Questions